Abstract
The affinities of 13 atypical and 12 typical antipsychotic drugs for the cloned rat D4 dopamine receptor and the D4/D2 ratios were examined. Of the atypical antipsychotic drugs tested, only clozapine, risperidone, olanzapine, zotepine and tiospirone had affinities less than 20 nM. In fact, many atypical antipsychotic drugs had relatively low affinities for the cloned rat D4 receptor, with Ki values greater than 100 nM (Seroquel, fluperlapine, tenilapine, FG5803 and melperone). Additionally, several typical antipsychotic drugs had high affinities for the cloned rat D4 receptor, with Kis less than 20 nM (loxapine, chlorpromazine, fluphenazine, mesoridazine, thioridazine and trifluoroperazine). The ratios of D2/D4 affinities did not differentiate between these two types of antipsychotic drugs. Thus, D4 dopamine receptor affinity, used as a single measure, does not distinguish between the group of typical and atypical antipsychotic drugs analyzed.
This is a preview of subscription content, log in via an institution to check access.
Reference
Altar CA, Boyer WC, Wasley A, Liebman JM, Wood PL, Gerhardt SG (1988) Dopamine neurochemical profile of atypical antipsychotics resemble that of D-1 antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 338:162–168
Anderson PH, Braestrup C (1986) Evidence for different affinity states of the dopamine D-1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D-1 receptor. J Neurochem 47:1830–1831
Ashgari V, Schoots O, VanKats S, Ohano K, Jovanovic V, Guan HC, Bunzow BR, Petronis A, Van Tol HH (1994) Dopamine D4 receptor repeat: analysis of distinct native and mutant forms of the human and rat genes. Mol Pharmacol 46:364–373
Beasley CM, Tolefson G, Tran P, Satterlee W, Sanger T, Hamilton S and the Olanzapine HGAD Study Group (1995) Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology (in press)
Bolden C, Cusack B, Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in chinese hamster ovary cells. J Pharmacol Exp Ther 260:576–580
Burgess LH, Sibley DR (1994) Expression and characterization of rat D4-D2 chimeric dopamine receptors. Soc Neurosci 20:525
Cohen BM, Lipinski JF (1986) In vivo potencies of antipsychotic drugs in blocking alphal noradrenergic and dopamine D-2 receptors: implications for drug mechanisms of action. Life Sci 39:2571–2586
Kane J, Honigfield G, Singer J, Meltzer HY and the Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789–796
Lahti RA, Evans DL, Stratman NC, Figur LM (1993) DopamineD4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. Eur J Pharmacol 236:483–486
Meltzer HY, Luchins DJ (1984) Effect of clozapine in severe tardive dyskinesia. J Clin Psychopharmacol 4:286–287
Meltzer HY, Goode DJ, Schyve PM, Young M, Fang VS (1979) Effect of clozapine on human serum prolactin levels. Am J Psychiatry 136:1550–1555
Meltzer HY, Matsubara S, Lee J-C (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238–246
Miller RJ, Hilley CR (1974) Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism. Nature 248:546–547
Munson PJ, Rodbard D (1980) LIGAND: a versatile, computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239
Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058–1066
Roth BL, Ciaranello RD, Meltzer HY (1992) Binding of typical and atypical antipsychotic agents with transiently expressed 5-HT1c receptors. J Pharmacol Exp Ther 260:1361–1365
Roth BL, Craigo SC, Choudhary MS, Monsma FJ, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine6 (5-HT6) and 5-hydroxytryptamine (5-HT7) receptors. J Pharmacol Exp Ther 256:1403–1410
Saller CF, Czupryna MJ, Salama AI (1990) 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade. J Pharmacol Exp Ther 253:1162–1170
Tang L, Todd RD, Heller A, O'Malley KL (1994) Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. Pharmacol Exp Ther 268:495–502
Van Tol HHM, Bunzow JR, Guan HC, Sunahara H-C, Seeman P, Niznik HB, Civelli O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610–614
Zorn SH, Jones SB, Ward KM, Liston DR (1994) Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur J Pharmacol 269:R1-R2
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roth, B.L., Tandra, S., Burgess, L.H. et al. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120, 365–368 (1995). https://doi.org/10.1007/BF02311185
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02311185